Skip to content
Open access

QTc Interval Prolongation and Its Association with Albuminuria Severity in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

Oct 2026 · National journal of medical research · 0 citations · 19 references

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) is associated with multiple microvascular complications, including diabetic nephropathy and cardiac autonomic dysfunction. Prolongation of the corrected QT (QTc) interval has emerged as a potential marker of cardiovascular risk, while albuminuria reflects early renal involvement. This study aimed to evaluate the association between QTc interval prolongation and albuminuria severity in patients with T2DM. Methods: A cross-sectional observational study was conducted among 100 patients with T2DM attending a tertiary care hospital. Clinical evaluation, laboratory investigations, urine albumin-to-creatinine ratio (UACR), and 12-lead electrocardiography were performed. Participants were categorized according to diabetes duration and UACR levels. Statistical analysis included independent Student’s t-test and one-way ANOVA, with p<0.05 considered statistically significant. Results: The mean age of the participants was 60.12±12.14 years, and 62% were females. Diabetic neuropathy and retinopathy were present in 66% and 63% of patients, respectively. Patients with diabetes duration ≥5 years had significantly higher UACR (141.28±75.40 vs. 100.33±64.41 mg/g; p=0.004), QT interval (384.22 ± 44.66 vs. 349.96 ± 43.58 ms; p=0.019), and QTc interval (489.29 ± 51.40 vs. 454.98 ± 50.51 ms; p=0.024) compared to those with shorter disease duration. A significant increase in HbA1c (p=0.005) and QTc interval (p=0.013) was observed across increasing UACR categories, indicating a dose-dependent relationship between albuminuria severity and cardiac repolarization abnormalities. Conclusion: QTc interval prolongation is significantly associated with increasing albuminuria severity, poor glycemic control, and longer diabetes duration. QTc assessment may serve as a simple, non-invasive marker for identifying T2DM patients at increased risk of microvascular and cardiovascular complications.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.